GFC Life Science지에프씨생명과학
388610 · KOSDAQ · ₩388610 · 지에프씨생명과학
₩4,275▼ ₩170 (3.82%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Gross margin | 50.0% | 48.0% | 46.9% |
| Operating margin | 4.4% | 2.2% | 10.1% |
| Net margin | 5.6% | 3.1% | −35.4% |
Growth (year on year)
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Revenue growth | +8.6% | +5.4% | — |
| Operating income growth | +117.7% | −77.3% | — |
| Net income growth | +93.6% | +109.3% | — |
Returns
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Return on equity | 4.4% | 3.2% | −54.6% |
| Return on assets | 3.0% | 2.1% | −29.7% |
Leverage and liquidity
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Liabilities to equity | 50.3% | 42.2% | 84.0% |
| Net debt to equity | 10.5% | −2.0% | 44.3% |
| Current ratio | 491.8% | 559.9% | 57.5% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: GFC Life Science / 지에프씨생명과학 / 388610 / KRX:388610
Source: KRX statistical information